Protein kinase C (PKC)ζ-mediated Gαq stimulation of ERK5 protein pathway in cardiomyocytes and cardiac fibroblasts

Journal of Biological Chemistry

Volumn 287, Issue 10, 2012, Pages 7792-7802

  García Hoz, Carlota ^a,b   Sánchez Fernández, Guzmán ^a,b   García Escudero, Ramón ^c   Fernández Velasco, María ^d   Palacios García, Julia ^a,b   Ruiz Meana, Marisol ^e   Díaz Meco, Maria Teresa ^f   Leitges, Michael ^g   Moscat, Jorge ^f   García Dorado, David ^e   Boscá, Lisardo ^h   Mayor, Federico ^a,b   Ribas, Catalina ^a,b  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas   (Spain)

^c CIEMAT   (Spain)

^d HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^e HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^f BURNHAM INSTITUTE   (United States)

^g UNIVERSITY OF OSLO   (Norway)

^h INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CELL SIGNALING; FIBROBLASTS; GENE EXPRESSION; HEART; MAMMALS; PATHOLOGY; PROTEINS;

ANGIOTENSIN II; CARDIAC CELL; CARDIAC FIBROBLASTS; CARDIAC HYPERTROPHY; CARDIOMYOCYTES; CARDIOVASCULAR FUNCTION; G PROTEIN COUPLED RECEPTORS; KEY REGULATORS; PROTEIN KINASES C; PROTEIN PATHWAYS;

CHEMICAL ACTIVATION;

ANGIOTENSIN II; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; MITOGEN ACTIVATED PROTEIN KINASE 7; PROTEIN KINASE C; PROTEIN KINASE C SIGMA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FIBROBLAST; GENE SEQUENCE; GENE SILENCING; HEART HYPERTROPHY; HEART MUSCLE CELL; IN VIVO STUDY; INTRACELLULAR SIGNALING; MALE; MICROARRAY ANALYSIS; MOUSE; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; UPREGULATION;

ANIMALIA; MURINAE; MUS;

EID: 84857768452     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.282210     Document Type: Article

References (74)

1. Dorn, G. W., 2nd, and Force, T. (2005) Protein kinase cascades in the regulation of cardiac hypertrophy. J. Clin. Invest. 115, 527-537
2. Harris, D. M., Eckhart, A. D., and Koch, W. J. (2006) Galphaq and its Aktions. J. Mol. Cell Cardiol. 40, 589-592
3. Wang, Y. (2007) Mitogen-activated protein kinases in heart development and diseases. Circulation 116, 1413-1423
4. Rohini, A., Agrawal, N., Koyani, C. N., and Singh, R. (2010) Molecular targets and regulators of cardiac hypertrophy. Pharmacol Res. 61, 269-280
5. Hein, L., Stevens, M. E., Barsh, G. S., Pratt, R. E., Kobilka, B. K., and Dzau, V. J. (1997) Overexpression of angiotensin AT1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block. Proc. Natl. Acad. Sci. U.S.A. 94, 6391-6396 (Pubitemid 27270695)
6. Paradis, P., Dali-Youcef, N., Paradis, F. W., Thibault, G., and Nemer, M. (2000) Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling. Proc. Natl. Acad. Sci. U.S.A. 97, 931-936 (Pubitemid 30070412)
7. Bueno, O. F., Wilkins, B. J., Tymitz, K. M., Glascock, B. J., Kimball, T. F., Lorenz, J. N., and Molkentin, J. D. (2002) Impaired cardiac hypertrophic response in calcineurin Aβ-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 99, 4586-4591 (Pubitemid 34286028)
8. Ikeda, Y., Aihara, K., Sato, T., Akaike, M., Yoshizumi, M., Suzaki, Y., Izawa, Y., Fujimura, M., Hashizume, S., Kato, M., Yagi, S., Tamaki, T., Kawano, H., Matsumoto, T., Azuma, H., and Kato, S. (2005) Androgen receptor gene knockout male mice exhibit impaired cardiac growth and exacerbation of angiotensin II-induced cardiac fibrosis. J. Biol. Chem. 280, 29661-29666 (Pubitemid 41177042)
9. Zhu, Y. C., Zhu, Y. Z., Gohlke, P., Stauss, H. M., and Unger, T. (1997) Effects of angiotensin-converting enzyme inhibition and angiotensin II AT1 receptor antagonism on cardiac parameters in left ventricular hypertrophy. Am. J. Cardiol. 80, 110A-117A (Pubitemid 27377483)
10. Hunyady, L., and Catt, K. J. (2006) Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II. Mol. Endocrinol. 20, 953-970
11. Liggett, S. B. (2006) Cardiac 7-transmembrane-spanning domain receptor portfolios: Diversify, diversify, diversify. J. Clin. Invest. 116, 875-877
12. Heineke, J., and Molkentin, J. D. (2006) Regulation of cardiac hypertrophy by intracellular signaling pathways. Nat. Rev. Mol. Cell Biol. 7, 589-600 (Pubitemid 44325350)
13. Mishra, S., Ling, H., Grimm, M., Zhang, T., Bers, D. M., and Brown, J. H. (2010) Cardiac hypertrophy and heart failure development through Gq and CaM kinase II signaling. J. Cardiovasc. Pharmacol. 56, 598-603
14. q and Gq-coupled receptors. J. Biol. Chem. 277, 27130-27134
15. Lutz, S., Freichel-Blomquist, A., Yang, Y., Rümenapp, U., Jakobs, K. H., Schmidt, M., and Wieland, T. (2005) The guanine nucleotide exchange factor p63RhoGEF, a specific link between Gq/11-coupled receptor signaling and RhoA. J. Biol. Chem. 280, 11134-11139 (Pubitemid 40418419)
16. q-p63RhoGEF-RhoA complex reveals a pathway for the activation of RhoA by GPCRs. Science 318, 1923-1927
17. q directly activates p63RhoGEF and Trio via a conserved extension of the Dbl homology-associated pleckstrin homology domain. J. Biol. Chem. 282, 29201-29210
18. García-Hoz, C., Sánchez-Fernández, G., Díaz-Meco, M. T., Moscat, J., Mayor, F., and Ribas, C. (2010)Gα(q) acts as an adaptor protein in protein kinase C ζ (PKCζ)-mediated ERK5 activation by G protein-coupled receptors (GPCR). J. Biol. Chem. 285, 13480-13489
19. Obara, Y., and Nakahata, N. (2010) The signaling pathway leading to extracellular signal-regulated kinase 5 (ERK5) activation via G-proteins and ERK5-dependent neurotrophic effects. Mol. Pharmacol. 77, 10-16
20. Wang, X., and Tournier, C. (2006) Regulation of cellular functions by the ERK5 signaling pathway. Cell Signal. 18, 753-760 (Pubitemid 43208930)
21. Nishimoto, S., and Nishida, E. (2006) MAPK signaling: ERK5 versus ERK1/2. EMBO Rep. 7, 782-786 (Pubitemid 44275395)
22. Roberts, O. L., Holmes, K., Müller, J., Cross, D. A., and Cross, M. J. (2009) ERK5 and the regulation of endothelial cell function. Biochem. Soc. Trans. 37, 1254-1259
23. Nicol, R. L., Frey, N., Pearson, G., Cobb, M., Richardson, J., and Olson, E. N. (2001) Activated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy. EMBO J. 20, 2757-2767 (Pubitemid 32938559)
24. Kacimi, R., and Gerdes, A. M. (2003) Alterations in G protein and MAP kinase signaling pathways during cardiac remodeling in hypertension and heart failure. Hypertension 41, 968-977 (Pubitemid 36418474)
25. Kimura, T. E., Jin, J., Zi, M., Prehar, S., Liu, W., Oceandy, D., Abe, J., Neyses, L., Weston, A. H., Cartwright, E. J., and Wang, X. (2010) Targeted deletion of the extracellular signal-regulated protein kinase 5 attenuates hypertrophic response and promotes pressure overload-induced apoptosis in the heart. Circ. Res. 106, 961-970
26. Xu, J., Gong, N. L., Bodi, I., Aronow, B. J., Backx, P. H., and Molkentin, J. D. (2006) Myocyte enhancer factors 2A and 2C induce dilated cardiomyopathy in transgenic mice. J. Biol. Chem. 281, 9152-9162 (Pubitemid 43864629)
27. Fernández-Velasco, M., Goren, N., Benito, G., Blanco-Rivero, J., Boscá, L., and Delgado, C. (2003) Regional distribution of hyperpolarization-activated current (If) and hyperpolarization-activated cyclic nucleotide-gated channel mRNA expression in ventricular cells from control and hypertrophied rat hearts. J. Physiol. 553, 395-405 (Pubitemid 37527543)
28. Xu, B. E., Stippec, S., Lenertz, L., Lee, B. H., Zhang, W., Lee, Y. K., and Cobb, M. H. (2004) WNK1 activates ERK5 by an MEKK2/3-dependent mechanism. J. Biol. Chem. 279, 7826-7831 (Pubitemid 38294668)
29. Nakamura, K., and Johnson, G. L. (2010) Activity assays for extracellular signal-regulated kinase 5. Methods Mol. Biol. 661, 91-106
30. Díaz-Rodríguez, E., and Pandiella, A. (2010) Multisite phosphorylation of Erk5 in mitosis. J. Cell Sci. 123, 3146-3156
31. Ohnesorge, N., Viemann, D., Schmidt, N., Czymai, T., Spiering, D., Schmolke, M., Ludwig, S., Roth, J., Goebeler, M., and Schmidt, M. (2010) Erk5 activation elicits a vasoprotective endothelial phenotype via induction of Kruppel-like factor 4 (KLF4). J. Biol. Chem. 285, 26199-26210
32. Elorza, A., Sarnago, S., and Mayor, F., Jr. (2000) Agonist-dependent modulation of G protein-coupled receptor kinase 2 by mitogen-activated protein kinases. Mol. Pharmacol. 57, 778-783 (Pubitemid 30183719)
33. Leitges, M., Sanz, L., Martin, P., Duran, A., Braun, U., García, J. F., Camacho, F., Diaz-Meco, M. T., Rennert, P. D., and Moscat, J. (2001) Targeted disruption of the zetaPKC gene results in the impairment of the NF-κB pathway. Mol. Cell 8, 771-780 (Pubitemid 33030211)
34. Braz, J. C., Bueno, O. F., Liang, Q., Wilkins, B. J., Dai, Y. S., Parsons, S., Braunwart, J., Glascock, B. J., Klevitsky, R., Kimball, T. F., Hewett, T. E., and Molkentin, J. D. (2003) Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through up-regulation of calcineurin- NFAT signaling. J. Clin. Invest. 111, 1475-1486 (Pubitemid 38063280)
35. Chu, V., Otero, J. M., Lopez, O., Morgan, J. P., Amende, I., and Hampton, T. G. (2001) Method for non-invasively recording electrocardiograms in conscious mice. BMC Physiol. 1, 6
36. Missbichler, A., Hawa, G., Schmal, N., and Woloszczuk, W. (2001) Sandwich ELISA for proANP 1-98 facilitates investigation of left ventricular dysfunction. Eur. J. Med. Res. 6, 105-111
37. Molhoek, S. G., Bax, J. J., van Erven, L., Bootsma, M., Steendijk, P., Lentjes, E., Boersma, E., van der Laarse, A., van der Wall, E. E., and Schalij, M. J. (2004) Atrial and brain natriuretic peptides as markers of response to resynchronization therapy. Heart 90, 97-98 (Pubitemid 38064558)
38. 2+ signaling in actin cytoskeleton remodeling and cell motility in prostate cancer. PloS one 5, e10456
39. Brey, E. M., Lalani, Z., Johnston, C., Wong, M., McIntire, L. V., Duke, P. J., and Patrick, C. W., Jr. (2003) Automated selection of DAB-labeled tissue for immunohistochemical quantification. J. Histochem. Cytochem. 51, 575-584 (Pubitemid 36520613)
40. Bolstad, B. M., Irizarry, R. A., Astrand, M., and Speed, T. P. (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19, 185-193 (Pubitemid 36181903)
41. Irizarry, R. A., Hobbs, B., Collin, F., Beazer-Barclay, Y. D., Antonellis, K. J., Scherf, U., and Speed, T. P. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4, 249-264
42. Kuba, K., Zhang, L., Imai, Y., Arab, S., Chen, M., Maekawa, Y., Leschnik, M., Leibbrandt, A., Markovic, M., Makovic, M., Schwaighofer, J., Beetz, N., Musialek, R., Neely, G. G., Komnenovic, V., Kolm, U., Metzler, B., Ricci, R., Hara, H., Meixner, A., Nghiem, M., Chen, X., Dawood, F., Wong, K. M., Sarao, R., Cukerman, E., Kimura, A., Hein, L., Thalhammer, J., Liu, P. P., and Penninger, J. M. (2007) Impaired heart contractility in Apelin gene-deficient mice associated with aging and pressure overload. Circ. Res. 101, e32-42 (Pubitemid 47267711)
43. Bisping, E., Ikeda, S., Kong, S. W., Tarnavski, O., Bodyak, N., McMullen, J. R., Rajagopal, S., Son, J. K., Ma, Q., Springer, Z., Kang, P. M., Izumo, S., and Pu, W. T. (2006) Gata4 is required for maintenance of postnatal cardiac function and protection from pressure overload-induced heart failure. Proc. Natl. Acad. Sci. U.S.A. 103, 14471-14476 (Pubitemid 44484774)
44. Smeets, P. J., de Vogel-van den Bosch, H. M., Willemsen, P. H., Stassen, A. P., Ayoubi, T., van der Vusse, G. J., and van Bilsen, M. (2008) Transcriptomic analysis of PPARα-dependent alterations during cardiac hypertrophy. Physiol. Genomics 36, 15-23
45. Hosack, D. A., Dennis, G., Jr., Sherman, B. T., Lane, H. C., and Lempicki, R. A. (2003) Identifying biological themes within lists of genes with EASE. Genome Biol. 4, R70
46. Dennis, G., Jr., Sherman, B. T., Hosack, D. A., Yang, J., Gao, W., Lane, H. C., and Lempicki, R. A. (2003) DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 4, P3
47. Parmentier, J. H., Smelcer, P., Pavicevic, Z., Basic, E., Idrizovic, A., Estes, A., and Malik, K. U. (2003) PKCζ mediates norepinephrine-induced phospholipase D activation and cell proliferation in VSMC. Hypertension 41, 794-800 (Pubitemid 36314593)
48. Godeny, M. D., and Sayeski, P. P. (2006)ANGII-induced cell proliferation is dually mediated by c-Src/Yes/Fyn-regulated ERK1/2 activation in the cytoplasm and PKCζ-controlled ERK1/2 activity within the nucleus. Am. J. Physiol. Cell Physiol. 291, C1297-1307 (Pubitemid 44878601)
49. Liao, Y., Asakura, M., Takashima, S., Ogai, A., Asano, Y., Shintani, Y., Minamino, T., Asanuma, H., Sanada, S., Kim, J., Kitamura, S., Tomoike, H., Hori, M., and Kitakaze, M. (2004) Celiprolol, a vasodilatory β-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice. Circulation 110, 692-699 (Pubitemid 39056268)
50. Mirotsou, M., Dzau, V. J., Pratt, R. E., and Weinberg, E. O. (2006) Physiological genomics of cardiac disease: Quantitative relationships between gene expression and left ventricular hypertrophy. Physiol. Genomics 27, 86-94 (Pubitemid 44511828)
51. Fielitz, J., Kim, M. S., Shelton, J. M., Qi, X., Hill, J. A., Richardson, J. A., Bassel-Duby, R., and Olson, E. N. (2008) Requirement of protein kinase D1 for pathological cardiac remodeling. Proc. Natl. Acad. Sci. U.S.A. 105, 3059-3063 (Pubitemid 351723667)
52. Larkin, J. E., Frank, B. C., Gaspard, R. M., Duka, I., Gavras, H., and Quackenbush, J. (2004) Cardiac transcriptional response to acute and chronic angiotensin II treatments. Physiol. Genomics 18, 152-166 (Pubitemid 39319497)
53. Hayashi, M., and Lee, J. D. (2004) Role of the BMK1/ERK5 signaling pathway: Lessons from knock-out mice. J. Mol. Med. 82, 800-808
54. Dhingra, R., Ho Nam, B., Benjamin, E. J., Wang, T. J., Larson, M. G., D'Agostino, R. B., Sr., Levy, D., and Vasan, R. S. (2005) Cross-sectional relations of electrocardiographic QRS duration to left ventricular dimensions: The Framingham Heart Study. J. Am. Coll. Cardiol. 45, 685-689 (Pubitemid 40278966)
55. Salles, G., Leocádio, S., Bloch, K., Nogueira, A. R., and Muxfeldt, E. (2005) Combined QT interval and voltage criteria improve left ventricular hypertrophy detection in resistant hypertension. Hypertension 46, 1207-1212 (Pubitemid 41533027)
56. Domenighetti, A. A., Boixel, C., Cefai, D., Abriel, H., and Pedrazzini, T. (2007) Chronic angiotensin II stimulation in the heart produces an acquired long QT syndrome associated with IK1 potassium current downregulation. J. Mol. Cell Cardiol. 42, 63-70 (Pubitemid 44958628)
57. Yamazaki, T., and Yazaki, Y. (1999) Role of tissue angiotensin II in myocardial remodeling induced by mechanical stress. J. Hum. Hypertens. 13, S43-47; discussion S49-50
58. Geng, J., Zhao, Z., Kang, W., Wang, W., Liu, G., Sun, Y., Zhang, Y., and Ge, Z. (2009) Hypertrophic response to angiotensin II is mediated by protein kinase D-extracellular signal-regulated kinase 5 pathway in human aortic smooth muscle cells. Biochem. Biophys. Res. Commun. 388, 517-522
59. Zhao, Z., Geng, J., Ge, Z., Wang, W., Zhang, Y., and Kang, W. (2009) Activation of ERK5 in angiotensin II-induced hypertrophy of human aortic smooth muscle cells. Mol. Cell Biochem. 322, 171-178
60. Zhao, Z., Wang, W., Geng, J., Wang, L., Su, G., Zhang, Y., Ge, Z., and Kang, W. (2010) Protein kinase C epsilon-dependent extracellular signal-regulated kinase 5 phosphorylation and nuclear translocation involved in cardiomyocyte hypertrophy with angiotensin II stimulation. J. Cell. Biochem. 109, 653-662
61. Takeishi, Y., Huang, Q., Abe, J., Glassman, M., Che, W., Lee, J. D., Kawakatsu, H., Lawrence, E. G., Hoit, B. D., Berk, B. C., and Walsh, R. A. (2001) Src and multiple MAP kinase activation in cardiac hypertrophy and congestive heart failure under chronic pressure overload: Comparison with acute mechanical stretch. J. Mol. Cell Cardiol. 33, 1637-1648 (Pubitemid 32844222)
62. Takeda, N., Manabe, I., Uchino, Y., Eguchi, K., Matsumoto, S., Nishimura, S., Shindo, T., Sano, M., Otsu, K., Snider, P., Conway, S. J., and Nagai, R. (2010) Cardiac fibroblasts are essential for the adaptive response of the murine heart to pressure overload. J. Clin. Invest. 120, 254-265
63. Kakkar, R., and Lee, R. T. (2010) Intramyocardial fibroblast myocyte communication. Circ. Res. 106, 47-57
64. Harris, D. M., Cohn, H. I., Pesant, S., and Eckhart, A. D. (2008) Clin. Sci. 115, 79-89
65. Filtz, T. M., Grubb, D. R., McLeod-Dryden, T. J., Luo, J., and Woodcock, E. A. (2009) Gq-initiated cardiomyocyte hypertrophy is mediated by phospholipase Cβ1b. FASEB J. 23, 3564-3570
66. Mende, U., Semsarian, C., Martins, D. C., Kagen, A., Duffy, C., Schoen, F. J., and Neer, E. J. (2001) Dilated cardiomyopathy in two transgenic mouse lines expressing activated G protein α(q): Lack of correlation between phospholipase C activation and the phenotype. J. Mol. Cell Cardiol. 33, 1477-1491 (Pubitemid 32681666)
67. Ecarnot-Laubriet, A., Assem, M., Poirson-Bichat, F., Moisant, M., Bernard, C., Lecour, S., Solary, E., Rochette, L., and Teyssier, J. R. (2002) Stage-dependent activation of cell cycle and apoptosis mechanisms in the right ventricle by pressure overload. Biochim. Biophys. Acta 1586, 233-242 (Pubitemid 34457919)
68. Zhan, Y., Brown, C., Maynard, E., Anshelevich, A., Ni, W., Ho, I. C., and Oettgen, P. (2005) Ets-1 is a critical regulator of Ang II-mediated vascular inflammation and remodeling. J. Clin. Invest. 115, 2508-2516 (Pubitemid 41266213)
69. Decock, J. B., Gillespie-Brown, J., Parker, P. J., Sugden, P. H., and Fuller, S. J. (1994) Classical, novel, and atypical isoforms of PKC stimulate ANF- and TRE/AP-1-regulated-promoter activity in ventricular cardiomyocytes. FEBS Lett. 356, 275-278
70. Wu, S. C., and Solaro, R. J. (2007) Protein kinase C ζ. A novel regulator of both phosphorylation and dephosphorylation of cardiac sarcomeric proteins. J. Biol. Chem. 282, 30691-30698 (Pubitemid 350035228)
71. Borges, L., Bigarella, C. L., Baratti, M. O., Crosara-Alberto, D. P., Joazeiro, P. P., Franchini, K. G., Costa, F. F., and Saad, S. T. (2008) ARHGAP21 associates with FAK and PKCζ and is redistributed after cardiac pressure overload. Biochem. Biophys. Res. Commun. 374, 641-646
72. Moscat, J., Rennert, P., and Diaz-Meco, M. T. (2006) PKCζ at the crossroad of NF-κB and Jak1/Stat6 signaling pathways. Cell. Death Differ. 13, 702-711
73. Moscat, J., and Diaz-Meco, M. T. (2011) Fine-tuning NF-κB: New openings for PKC-ζ. Nat. Immunol. 12, 12-14
74. Sentex, E., Wang, X., Liu, X., Lukas, A., and Dhalla, N. S. (2006) Expression of protein kinase C isoforms in cardiac hypertrophy and heart failure due to volume overload. Can. J. Physiol. Pharmacol. 84, 227-238 (Pubitemid 43901431)